BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22511779)

  • 1. PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing.
    Zimmerman R; Peng DJ; Lanz H; Zhang YH; Danen-Van Oorschot A; Qu S; Backendorf C; Noteborn M
    Cell Death Dis; 2012 Apr; 3(4):e291. PubMed ID: 22476099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cell adhesion by PP2A and SV40 small tumor antigen: an important link to cell transformation.
    Sontag JM; Sontag E
    Cell Mol Life Sci; 2006 Dec; 63(24):2979-91. PubMed ID: 17072501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo.
    Lambrecht C; Libbrecht L; Sagaert X; Pauwels P; Hoorne Y; Crowther J; Louis JV; Sents W; Sablina A; Janssens V
    Oncogene; 2018 Jan; 37(4):544-552. PubMed ID: 28967903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies.
    Knudsen ES; Witkiewicz AK
    Trends Cancer; 2017 Jan; 3(1):39-55. PubMed ID: 28303264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.
    Ruvolo PP
    BBA Clin; 2016 Dec; 6():87-99. PubMed ID: 27556014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B56γ3 regulatory subunit-containing protein phosphatase 2A outcompetes Akt to regulate p27KIP1 subcellular localization by selectively dephosphorylating phospho-Thr157 of p27KIP1.
    Lai TY; Yen CJ; Tsai HW; Yang YS; Hong WF; Chiang CW
    Oncotarget; 2016 Jan; 7(4):4542-58. PubMed ID: 26684356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus.
    Forte E; Raja AN; Shamulailatpam P; Manzano M; Schipma MJ; Casey JL; Gottwein E
    J Virol; 2015 Feb; 89(4):2333-41. PubMed ID: 25505059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.
    Fish K; Chen J; Longnecker R
    Blood; 2014 Jan; 123(4):530-40. PubMed ID: 24174629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The B55α regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes.
    Kolupaeva V; Daempfling L; Basilico C
    Mol Cell Biol; 2013 Aug; 33(15):2865-78. PubMed ID: 23716589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV40 small T antigen and PP2A phosphatase in cell transformation.
    Sablina AA; Hahn WC
    Cancer Metastasis Rev; 2008 Jun; 27(2):137-46. PubMed ID: 18214640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular targets of the SV40 small-t antigen in human cell transformation.
    Skoczylas C; Fahrbach KM; Rundell K
    Cell Cycle; 2004 May; 3(5):606-10. PubMed ID: 15034297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27kip1 protein levels reflect a nexus of oncogenic signaling during cell transformation.
    Miller JP; Yeh N; Hofstetter CP; Keskin D; Goldstein AS; Koff A
    J Biol Chem; 2012 Jun; 287(24):19775-85. PubMed ID: 22511779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.
    Kwun HJ; Shuda M; Camacho CJ; Gamper AM; Thant M; Chang Y; Moore PS
    J Virol; 2015 Apr; 89(8):4191-200. PubMed ID: 25631078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner.
    Jackson JB; Pallas DC
    Neoplasia; 2012 Jul; 14(7):585-99. PubMed ID: 22904676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen.
    Kotadia S; Kao LR; Comerford SA; Jones RT; Hammer RE; Megraw TL
    Oncogene; 2008 Oct; 27(49):6334-46. PubMed ID: 18663356
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.